CC-220
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for CC-220, covering 2014-01-13 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma [Phase 1]